210 related articles for article (PubMed ID: 28184213)
1. Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease.
Heinrich G; Ghadieh HE; Ghanem SS; Muturi HT; Rezaei K; Al-Share QY; Bowman TA; Zhang D; Garofalo RS; Yin L; Najjar SM
Front Endocrinol (Lausanne); 2017; 8():8. PubMed ID: 28184213
[TBL] [Abstract][Full Text] [Related]
2. Loss of CEACAM1 in hepatocytes causes hepatic fibrosis.
Zaidi S; Asalla S; Muturi HT; Russo L; Abdolahipour R; Belew GD; Iglesias MB; Feraudo M; Leon L; Kuo E; Liu X; Kumarasamy S; Ghadieh HE; Gatto-Weis C; Zarrinpar A; Duarte S; Najjar SM
Eur J Clin Invest; 2024 Jul; 54(7):e14177. PubMed ID: 38381498
[TBL] [Abstract][Full Text] [Related]
3. Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1.
Helal RA; Russo L; Ghadieh HE; Muturi HT; Asalla S; Lee AD; Gatto-Weis C; Najjar SM
Metabolism; 2021 Aug; 121():154801. PubMed ID: 34058224
[TBL] [Abstract][Full Text] [Related]
4. Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.
Al-Share QY; DeAngelis AM; Lester SG; Bowman TA; Ramakrishnan SK; Abdallah SL; Russo L; Patel PR; Kaw MK; Raphael CK; Kim AJ; Heinrich G; Lee AD; Kim JK; Kulkarni RN; Philbrick WM; Najjar SM
Diabetes; 2015 Aug; 64(8):2780-90. PubMed ID: 25972571
[TBL] [Abstract][Full Text] [Related]
5. Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.
Russo L; Ghadieh HE; Ghanem SS; Al-Share QY; Smiley ZN; Gatto-Weis C; Esakov EL; McInerney MF; Heinrich G; Tong X; Yin L; Najjar SM
J Lipid Res; 2016 Dec; 57(12):2163-2175. PubMed ID: 27777319
[TBL] [Abstract][Full Text] [Related]
6. Loss of Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Links Nonalcoholic Steatohepatitis to Atherosclerosis.
Ghadieh HE; Abu Helal R; Muturi HT; Issa DD; Russo L; Abdallah SL; Najjar JA; Benencia F; Vazquez G; Li W; Najjar SM
Hepatol Commun; 2020 Nov; 4(11):1591-1609. PubMed ID: 33163831
[TBL] [Abstract][Full Text] [Related]
7. Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.
Russo L; Muturi HT; Ghadieh HE; Ghanem SS; Bowman TA; Noh HL; Dagdeviren S; Dogbey GY; Kim JK; Heinrich G; Najjar SM
Diabetologia; 2017 Dec; 60(12):2463-2474. PubMed ID: 28913658
[TBL] [Abstract][Full Text] [Related]
8. Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Obesity.
Heinrich G; Muturi HT; Rezaei K; Al-Share QY; DeAngelis AM; Bowman TA; Ghadieh HE; Ghanem SS; Zhang D; Garofalo RS; Yin L; Najjar SM
Front Endocrinol (Lausanne); 2017; 8():54. PubMed ID: 28396653
[TBL] [Abstract][Full Text] [Related]
9. Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis.
Ghadieh HE; Russo L; Muturi HT; Ghanem SS; Manaserh IH; Noh HL; Suk S; Kim JK; Hill JW; Najjar SM
Metabolism; 2019 Apr; 93():33-43. PubMed ID: 30664851
[TBL] [Abstract][Full Text] [Related]
10. Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose Tissue.
Lester SG; Russo L; Ghanem SS; Khuder SS; DeAngelis AM; Esakov EL; Bowman TA; Heinrich G; Al-Share QY; McInerney MF; Philbrick WM; Najjar SM
Front Endocrinol (Lausanne); 2015; 6():116. PubMed ID: 26284027
[TBL] [Abstract][Full Text] [Related]
11. Leptin Resistance Contributes to Obesity in Mice with Null Mutation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1.
Heinrich G; Russo L; Castaneda TR; Pfeiffer V; Ghadieh HE; Ghanem SS; Wu J; Faulkner LD; Ergün S; McInerney MF; Hill JW; Najjar SM
J Biol Chem; 2016 May; 291(21):11124-32. PubMed ID: 27002145
[TBL] [Abstract][Full Text] [Related]
12. Exenatide induces carcinoembryonic antigen-related cell adhesion molecule 1 expression to prevent hepatic steatosis.
Ghadieh HE; Muturi HT; Russo L; Marino CC; Ghanem SS; Khuder SS; Hanna JC; Jash S; Puri V; Heinrich G; Gatto-Weis C; Lee KY; Najjar SM
Hepatol Commun; 2018 Jan; 2(1):35-47. PubMed ID: 29404511
[TBL] [Abstract][Full Text] [Related]
13. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).
Najjar SM; Russo L
Semin Immunopathol; 2014 Jan; 36(1):55-71. PubMed ID: 24258517
[TBL] [Abstract][Full Text] [Related]
14. CEACAM1 in Liver Injury, Metabolic and Immune Regulation.
Horst AK; Najjar SM; Wagener C; Tiegs G
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314283
[TBL] [Abstract][Full Text] [Related]
15. Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene.
Russo L; Muturi HT; Ghadieh HE; Wisniewski AM; Morgan EE; Quadri SS; Landesberg GP; Siragy HM; Vazquez G; Scalia R; Gupta R; Najjar SM
Mol Metab; 2018 Mar; 9():98-113. PubMed ID: 29396368
[TBL] [Abstract][Full Text] [Related]
16. Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.
Ghosh S; Kaw M; Patel PR; Ledford KJ; Bowman TA; McInerney MF; Erickson SK; Bourey RE; Najjar SM
Hepat Med; 2010 May; 2010(2):69-78. PubMed ID: 21949477
[TBL] [Abstract][Full Text] [Related]
17. Exenatide Prevents Diet-induced Hepatocellular Injury in A CEACAM1-Dependent Mechanism.
Ghadieh HE; Muturi HT; Najjar SM
J Diabetes Treat; 2017; 2017(4):. PubMed ID: 29431170
[TBL] [Abstract][Full Text] [Related]
18. Loss of CEACAM1 in endothelial cells causes hepatic fibrosis.
Muturi HT; Ghadieh HE; Abdolahipour R; Stankus HL; Belew GD; Liu JK; Jahromi MS; Lee AD; Singer BB; Angeli-Pahim I; Sehrawat TS; Malhi H; Verhulst S; van Grunsven LA; Zarrinpar A; Duarte S; Najjar SM
Metabolism; 2023 Jul; 144():155562. PubMed ID: 37088122
[TBL] [Abstract][Full Text] [Related]
19. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
20. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
